Clinical Features and Treatment Options of Vogt-Koyanagi-Harada Disease

    May 2025 in “ IntechOpen eBooks ”
    Mustafa Kayabaşı
    Studysummary This article highlights that early and high-dose corticosteroid therapy, along with immunosuppressive agents, is crucial for managing Vogt-Koyanagi-Harada disease, and emerging biological therapies may benefit refractory cases.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on intechopen.com →
    Discuss this study in the Community →